香港股市 已收市

ZY Jan 2024 2.500 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.85000.0000 (0.00%)
市場開市。 截至 10:24AM EDT。
全螢幕
正在載入互動式股價圖表...
  • Benzinga

    Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal

    Ginkgo Bioworks Holdings Inc (NYSE: DNA) agreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction. Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo. Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, incl